Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCBE1 antisense RNA 1 (CCBE1-AS1) is a long non-coding RNA transcribed from the antisense strand of the *CCBE1* gene locus. While the protein-coding gene *CCBE1* is well-studied for its role in lymphatic vascular development, tumor biology, cardiac development, and disease[1][2][3][4], CCBE1-AS1 itself is not characterized in the current literature. There is no evidence from recent biomedical sources that CCBE1-AS1 is a therapeutic target, drug-interacting molecule, or clinically relevant biomarker. Its molecular and biological functions, clinical or disease roles, and pharmacological relevance remain unknown or unreported in published research. If you intended information for the protein-coding gene *CCBE1* (Collagen and calcium-binding EGF domains 1), which is relevant in lymphangiogenesis, cancer, and genetic syndromes, or for its protein, please clarify, as abundant data is available for that entity[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCBE1 antisense RNA 1 (CCBE1-AS1).